30745005: Loxapine succinate (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Central nervous system agent (substance)\Psychoactive substance (substance)\Psychotropic agent (substance)\Anti-psychotic agent (substance)\Loxapine succinate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Heterocyclic compound\Dibenzoxazepine compound (substance)\Loxapine succinate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

51450017 Loxapine succinate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

51451018 Oxilapine succinate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

761788013 Loxapine succinate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

821661000172118 succinate de loxapine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Loxapine succinate	Is a	Product containing loxapine (medicinal product)	false	Inferred relationship	Some
Loxapine succinate	Is a	Loxapine (substance)	false	Inferred relationship	Some
Loxapine succinate	Is a	Dibenzoxazepine compound (substance)	true	Inferred relationship	Some
Loxapine succinate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Loxapine (substance)	true	Inferred relationship	Some
Loxapine succinate	Is a	Anti-psychotic agent (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely loxapine succinate 5 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Loxapine succinate	Inferred relationship	Some
Product containing precisely loxapine succinate 5 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Loxapine succinate	Inferred relationship	Some	1
Product containing precisely loxapine succinate 5 milligram/1 each conventional release oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Loxapine succinate	Inferred relationship	Some	1
Product containing precisely loxapine succinate 5 milligram/1 each conventional release oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Loxapine succinate	Inferred relationship	Some	1
Product containing precisely loxapine (as loxapine succinate) 10 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Loxapine succinate	Inferred relationship	Some	1
Product containing precisely loxapine (as loxapine succinate) 25 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Loxapine succinate	Inferred relationship	Some	1
Product containing precisely loxapine (as loxapine succinate) 50 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Loxapine succinate	Inferred relationship	Some	1
Loxapine (as loxapine succinate) 5 mg oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Loxapine succinate	Inferred relationship	Some	1

Reference Sets

Description inactivation indicator reference set